These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16358633)

  • 1. [Hypertension and stroke: new publications in 2005].
    Schrader J
    MMW Fortschr Med; 2005 Nov; 147(46):40-2, 44. PubMed ID: 16358633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
    Devereux RB; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):443-57. PubMed ID: 17288698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New tendencies in combination antihypertensive therapy].
    van der Giet M; Paul M
    MMW Fortschr Med; 2005 Nov; 147(46):44-6. PubMed ID: 16358634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The best of hypertension 2005].
    Chamontin B
    Arch Mal Coeur Vaiss; 2006 Jan; 99 Spec No 1(1):35-41. PubMed ID: 16479962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of blood pressure control on cardiovascular events in 26,512 Japanese hypertensive patients: the Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study, a prospective nationwide observational study.
    Shimamoto K; Fujita T; Ito S; Naritomi H; Ogihara T; Shimada K; Tanaka H; Yoshiike N;
    Hypertens Res; 2008 Mar; 31(3):469-78. PubMed ID: 18497466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Action on vascular risk factors: importance of blood pressure and lipid lowering in stroke secondary prevention.
    Fuentes B; Ortega-Casarrubios MA; Martínez P; Díez-Tejedor E
    Cerebrovasc Dis; 2007; 24 Suppl 1():96-106. PubMed ID: 17971644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
    Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ;
    Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure control and drug therapy in patients with diagnosed hypertension: a survey in Italian general practice.
    Filippi A; Paolini I; Innocenti F; Mazzaglia G; Battaggia A; Brignoli O
    J Hum Hypertens; 2009 Nov; 23(11):758-63. PubMed ID: 19242492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reappraisal of guidelines on hypertension management].
    Spinar J; Soucek M
    Vnitr Lek; 2010 Feb; 56(2):157-61. PubMed ID: 20329588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recent development of recommendations for the screening and treatment of arterial hypertension].
    Plouin PF; Bobrie G
    Bull Acad Natl Med; 2002; 186(9):1611-21; discussion 1621-3. PubMed ID: 14556577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atenolol as a comparator in outcome trials in hypertension: a correct choice in the past, but not for the future?
    Dahlöf B; Devereux RB; Kjeldsen SE; Lyle PA; Zhang Z; Edelman JM
    Blood Press; 2007; 16(1):6-12. PubMed ID: 17453746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospects for the prevention of stroke.
    Dahlöf B
    J Hypertens Suppl; 2006 Apr; 24(2):S3-9. PubMed ID: 16601558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing hypertension using combination therapy.
    Frank J
    Am Fam Physician; 2008 May; 77(9):1279-86. PubMed ID: 18540493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypertension 2007-2008].
    Chatzikyrkou C; Menne J; Haller H
    Med Klin (Munich); 2009 Aug; 104(8):614-21. PubMed ID: 19701732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive treatment and stroke prevention: are angiotensin receptor blockers superior to other antihypertensive agents?
    Armario P; de la Sierra A
    Ther Adv Cardiovasc Dis; 2009 Jun; 3(3):197-204. PubMed ID: 19443514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does treatment of hypertension decrease the incidence of atrial fibrillation and cardioembolic stroke?
    Solun B; Marcoviciu D; Dicker D
    Eur J Intern Med; 2009 Mar; 20(2):125-31. PubMed ID: 19327599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.